LCR1 and LCR2, two multi‐analyte blood tests to assess liver cancer risk in patients without or with cirrhosis

BACKGROUND: No blood test has been shown to be effective in the prediction of primary liver cancer in patients without cirrhosis. AIM: To construct and internally validate two sequential tests for early prediction of liver cancer. These tests enable an algorithm which could improve the performance o...

Descripción completa

Detalles Bibliográficos
Autores principales: Poynard, Thierry, Peta, Valentina, Deckmyn, Olivier, Munteanu, Mona, Moussalli, Joseph, Ngo, Yen, Rudler, Marika, Lebray, Pascal, Pais, Raluca, Bonyhay, Luminita, Charlotte, Frederic, Thibault, Vincent, Fartoux, Laetitia, Lucidarme, Olivier, Eyraud, Daniel, Scatton, Olivier, Savier, Eric, Valantin, Marc Antoine, Ngo, An, Drane, Fabienne, Rosmorduc, Olivier, Imbert‐Bismut, Françoise, Housset, Chantal, Thabut, Dominique, Ratziu, Vlad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Lcr1 and Lcr2 Blood Tests for Hepatoma Screening
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590635/
https://www.ncbi.nlm.nih.gov/pubmed/30569507
http://dx.doi.org/10.1111/apt.15082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590635/
https://www.ncbi.nlm.nih.gov/pubmed/30569507
http://dx.doi.org/10.1111/apt.15082

Ejemplares similares